Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 2% on Tuesday.
The Dow traded down 2.06% to 33,129.04 while the NASDAQ fell 2.39% to 11,506.10. The S&P 500 also fell, dropping, 2.05% to 3,995.66.
Gainers
Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 500 points on Tuesday.
The Dow traded down 1.61% to 33,280.92 while the NASDAQ fell 2.05% to 11,545.79. The S&P 500 also fell, dropping, 1.65% to 4,011.67.
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping more than 100 points on Tuesday.
Following the market opening Tuesday, The Dow traded down 1.15% to 33,438.86 while the NASDAQ fell 1.24% to 11,640.85. The S&P 500 also fell, dropping, 1.03% to 4,037.11.
Arbe Robotics (NASDAQ:ARBE) reported adj quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 86.9 percent increase over losses of $(0.84) per share from
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.